calcium acetate NDC 70518-4299

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4299Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4299Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4299-0	70518429900	30 CAPSULE in 1 BLISTER PACK (70518-4299-0)Marketed from Mar 2, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): calcium acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202315
Marketing start: Mar 2, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 70518-4299_5a98215f-03e5-b9af-e063-6394a90a00f7SPL ID 5a98215f-03e5-b9af-e063-6394a90a00f7SPL set ID 89a2ee04-1024-4a81-ba0d-a6655d529827RxCUI 359296UNII Y882YXF34X
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518429900 followed by a unit qualifier and the quantity

Package 70518-4299-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 3, 2026.

Indications (excerpt from the label)

Calcium acetate capsule is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. ( 1 ) Calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202315

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202315
Product	Strength	Form · route	Labeler	Product NDC
calcium acetate	Calcium acetate 667 mg/1	CapsuleOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-531
calcium acetate	Calcium acetate 667 mg/1	CapsuleOral	AvKARE	73190-031